Immediate Impact

3 standout
Sub-graph 1 of 2

Citing Papers

Interstitial Lung Disease
2024 Standout
Guidelines on the Use of Therapeutic Apheresis in Clinical Practice – Evidence‐Based Approach from the Writing Committee of the American Society for Apheresis: The Ninth Special Issue
2023 Standout
1 intermediate paper

Works of Albert Gil‐Vila being referenced

Role of autoantibodies in the diagnosis and prognosis of interstitial lung disease in autoimmune rheumatic disorders
2021
Malignancy and myositis, from molecular mimicry to tumor infiltrating lymphocytes
2019

Author Peers

Author Last Decade Papers Cites
Albert Gil‐Vila 94 54 9 37 15 122
Paloma García de la Peña Lefebvre 89 52 21 34 13 137
G. Natalello 31 32 30 29 22 150
Mariko Ogawa‐Momohara 81 48 5 6 19 102
Laura Gigante 30 26 34 46 17 171
Lucrezia Verardi 30 27 42 28 14 155
C Bachmeyer 53 58 44 28 22 185
TI Kaya 55 48 13 23 16 189
Kaarina Heiskanen 60 56 17 10 17 182
Vincent Langlois 42 33 14 57 19 147
H. Henry Lai 77 91 30 21 15 222

All Works

Loading papers...

Rankless by CCL
2026